Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;26(1):59-72.
doi: 10.2174/0113894501328461240921062056.

An Overview of Research Advances in Oncology Regarding the Transcription Factor ATF4

Yulu Chen  1 , Qi Gao  1 , Dan Wang  1 , Xun Zou  1 , Xiuming Li  1 , Jing Ji  1 , Bin Liu  1
Affiliations
Review

An Overview of Research Advances in Oncology Regarding the Transcription Factor ATF4

Yulu Chen et al. Curr Drug Targets. 2025.

Abstract

This review provides a comprehensive overview of the recent advancements in research on ATF4 (Activating Transcription Factor 4) within the field of oncology. As a crucial transcription factor, ATF4 has garnered increasing attention for its role in cancer research. The review begins with an exploration of the regulatory mechanisms of ATF4, including its transcriptional control, post-translational modifications, and interactions with other transcription factors. It then highlights key research findings on ATF4's involvement in various aspects of tumor biology, such as cell proliferation, differentiation, apoptosis and survival, invasion and metastasis, and the tumor microenvironment. Furthermore, the review discusses the potential of targeting ATF4 as a novel therapeutic strategy for cancer treatment. It also explores how ATF4's interactions with existing anticancer drugs could inform the development of more effective therapeutic agents. By elucidating the role of ATF4 in tumor biology and its potential clinical applications, this review aims to provide new insights and strategies for cancer treatment.

Keywords: ATF4; ER stress.; malignant; targeted therapy; transcription factor; tumor.

PubMed Disclaimer

References

    1. Global cancer burden growing, amidst mounting need for services. Saudi Med J 2024,45(3),326-327 - PubMed
    1. Dizon D.S.; Kamal A.H.; Cancer statistics 2024: All hands on deck. CA Cancer J Clin 2024,74(1),8-9 - DOI - PubMed
    1. Qi J.; Li M.; Wang L.; Hu Y.; Liu W.; Long Z.; Zhou Z.; Yin P.; Zhou M.; National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data. Lancet Public Health 2023,8(12),e943-e955 - DOI - PubMed
    1. van Hoogstraten L.M.C.; Vrieling A.; van der Heijden A.G.; Kogevinas M.; Richters A.; Kiemeney L.A.; Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol 2023,20(5),287-304 - DOI - PubMed
    1. Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021,71(3),209-249 - DOI - PubMed

MeSH terms

Substances